Medorisper (Risperidone)

Risperidone is an atypical antipsychotic used across several psychiatric indications.

• Schizophrenia: reduces psychotic symptoms such as delusions and hallucinations.
• Bipolar I disorder (manic episodes): helps control mood elevation and agitation.
• Irritability associated with autistic disorder: lessens aggression and temper outbursts.
• Maintenance treatment of schizophrenia: sustains symptom control after acute stabilization.

• Risperidone acts as an antagonist at dopamine D2 receptors and serotonin 5‑HT2A receptors, modulating dopaminergic and serotonergic neurotransmission. This combined blockade reduces positive psychotic symptoms while improving mood stability, and it also influences other neurotransmitter pathways that contribute to its therapeutic profile in schizophrenia and bipolar disorder.

Risperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Weight gain: increase in body mass index over time.
• Sedation: drowsiness or reduced alertness.
• Dizziness: sensation of light‑headedness, especially on standing.
• Elevated prolactin: menstrual changes or galactorrhea.
• Constipation: reduced bowel movements.
• Dry mouth: decreased salivation.

Serious or Rare Side Effects

• Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity.
• Tardive dyskinesia: involuntary, repetitive movements.
• Agranulocytosis: severe reduction in white blood cells.
• Severe hypotension: marked drop in blood pressure.
• Seizures: increased risk in predisposed individuals.
• Myocarditis: inflammation of the heart muscle.

Before initiating risperidone therapy, several safety considerations should be reviewed.

• Metabolic monitoring: regularly assess weight, glucose, and lipid levels.
• Extrapyramidal assessment: watch for tremor, rigidity, or abnormal movements.
• Cardiac evaluation: obtain baseline ECG if patient has cardiac risk factors.
• Hepatic/renal function: adjust use in patients with liver or kidney impairment.
• Pregnancy and lactation: discuss potential risks with the prescriber.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Risperidone can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

• Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase risperidone levels.
• CNS depressants (e.g., alcohol, benzodiazepines): additive sedation and respiratory depression.
• Antihypertensive agents: risk of excessive blood pressure lowering.

Moderate Interactions (Monitor Closely)

• Anticholinergic drugs: may mask extrapyramidal symptoms.
• Other antipsychotics: increased risk of QT prolongation.
• CYP inducers (e.g., carbamazepine, phenytoin): may reduce risperidone exposure.
• Histamine antagonists: may enhance sedation.